Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

March 31, 2011 By Bio-Medicine.Org

SAN DIEGO, March 31, 2011 /PRNewswire/ — Accumetrics, Inc.,
developer of the VerifyNow® System, the first rapid and
easy-to-use point-of-care system for measuring platelet reactivity
to multiple antiplatelet agents, announced today that a new
recommendation for platelet reactivity testing has been
incorporated into the updated 2011 ACCF/AHA Guidelines for the
Management of UA/NSTEMI Patients.

The Guidelines, published online in the Journal of the
American College of Cardiology
(1), signify the growing
focus and importance of platelet reactivity testing in a variety of
patient populations, including UA/NSTEMI and ACS/PCI. The IIb (B)
recommendation suggests that an approach of assessing platelet
reactivity in combination with other procedural and patient
characteristics may be considered to aid in patient management
decisions.

“The addition of platelet reactivity testing to the Guidelines
captures what we have already implemented at Scripps,” said Matthew
J. Price, MD, of the Scripps Translational Science Institute and
Scripps Clinic in La Jolla, CA. “We believe that when considering
alternative approaches for the management of patients that require
antiplatelet therapy, an individualized approach that incorporates
platelet reactivity testing is warranted in an attempt to minimize
further ischemic events.”

The Update also provides guidance on the rapidly expanding
treatment options for patients requiring antiplatelet medications.
“With the availability of newer antiplatelet agents, it has become
challenging for a physician to determine how to manage individual
patients,” stated Kevin Croce, MD, PhD, Interventional Cardiologist
at Brigham and Women’s Hospital. “By utilizing platelet reactivity
testing as recommended in this new Guideline, we feel we have a
clearer picture on how to optimally manage our patients at the
Brigham in this increasingly complex clinical setting.”

The release of these Guidelines further el

‘/>”/>

SOURCE

Related Articles Read More >

Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech